sarscov
share
common
human
receptor
proteinprotein
interact
structur
model
indic
spikerbd
two
virus
also
similar
overal
bind
conform
bind
free
energi
vitro
assay
use
recombin
protein
express
cell
confirm
two
coronavirus
similar
bind
affin
studi
provid
experiment
support
evid
possibl
explan
high
transmiss
observ
outbreak
potent
sarscov
neutral
antibodi
show
limit
crossbind
neutral
activ
sarscov
rbd
antibodi
though
weaker
neutral
activ
sarscov
show
posit
crossneutr
activ
unknown
mechan
find
suggest
tradeoff
efficaci
spectrum
therapeut
antibodi
differ
coronavirus
henc
highlight
possibl
challeng
develop
broadli
protect
antibodi
vaccin
futur
mutant
variou
estim
analys
suggest
sever
acut
respiratori
syndrom
coronaviru
sarscov
may
similar
transmiss
estim
reproduct
number
r
sarscov
sarscov
share
common
hostcel
receptor
protein
angiotensin
convert
enzym
express
epitheli
cell
respiratori
track
system
variou
human
organ
lung
receptor
recognit
coronavirus
first
essenti
step
infect
host
cell
envelopeanchor
trimer
spike
protein
mediat
bind
two
coronavirus
human
cleav
host
proteas
two
separ
polypeptid
contain
receptor
bind
domain
rbd
respons
homotrim
format
mediat
fusion
virion
cellular
membran
receptor
bind
motif
rbm
rbd
respons
direct
bind
bind
affin
may
directli
affect
viru
infect
transmiss
amino
acid
sequenc
homolog
sarscov
approxim
spike
protein
rbd
rbm
respect
investig
optim
complex
structur
conform
rbd
decemb
outbreak
infect
brought
back
attent
pathogen
coronaviru
spotlight
spread
rapidli
caus
sever
symptom
lifethreaten
diseas
infect
patient
number
infect
case
reach
less
month
promin
sequenc
differ
crucial
rbm
sarscov
rais
critic
question
whether
bind
affin
spike
protein
human
compar
sarscov
recent
studi
comput
model
suggest
lower
bind
affin
human
result
loss
one
hydrogen
bond
interact
howev
anoth
public
use
structur
analysi
suggest
similar
bind
affin
sarscov
use
biolay
interferometri
bind
assay
tian
et
al
measur
rbd
bind
affin
human
protein
nm
compar
previous
publish
affin
data
sarscov
spike
protein
comparison
spike
protein
bind
affin
human
sarscov
inconclus
indirect
henc
direct
headtohead
comparison
desir
understand
infect
transmiss
viru
neutral
antibodi
nab
expect
one
promis
treatment
coronaviru
infect
among
exist
therapeut
option
sever
nab
target
sarscov
exhibit
signific
vivo
antiviru
activ
reduc
viru
titer
lung
tissu
anim
model
howev
coronaviru
singlestrand
rna
viru
prone
rapid
mutat
transmiss
nab
without
crossreact
broad
spectrum
viral
mutant
could
lead
treatment
failur
therefor
highli
potent
crossprotect
nab
prophylact
vaccin
urgent
need
comput
model
bind
free
energi
analysi
also
use
recombin
protein
two
virus
compar
bind
curv
recombin
protein
express
cell
studi
confirm
sarscov
similar
bind
affin
human
receptor
due
rel
low
homolog
spike
rbd
sarscov
signific
interest
investig
whether
sarscov
neutral
antibodi
possess
crossreact
sarscov
polyclon
antibodi
block
nonblock
nab
test
pseudoviru
psv
cross
neutral
activ
structur
model
complex
optim
base
complex
crystal
structur
pdb
id
http
wwwrcsborg
structur
model
complex
construct
homolog
model
use
optim
sarscov
complex
crystal
structur
templat
base
amino
acid
sequenc
homolog
two
virus
rootmeansquar
deviat
rmsd
atom
two
complex
structur
indic
almost
ident
structur
conform
subtl
differ
interfac
sarscov
loop
number
accord
sarscov
rbd
aris
oneresidu
insert
residu
figur
hand
interact
pattern
complex
structur
interfac
somewhat
differ
figur
tabl
four
residu
rbd
ie
lost
interact
compar
correspond
residu
sarscov
rbd
ie
four
replac
residu
rbd
ie
form
new
interact
absent
sarscov
rbd
correspond
figur
c
noteworthi
although
strong
saltbridg
present
sarscov
rbd
miss
interact
involv
rbd
howev
new
strong
saltbridg
interact
rbd
compens
loss
bind
free
energi
sarscov
estim
reu
rosetta
energi
unit
respect
tabl
rosetta
interfac
analyz
insignific
differ
bind
free
energi
suggest
sarscov
virus
similar
bind
affin
human
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
recombin
protein
show
similar
bind
human
protein
cellular
form
compar
sarscov
rbd
contain
protein
result
cleavag
spike
protein
viru
membran
respons
bind
viru
human
receptor
cell
membran
import
viral
infect
bind
curv
recombin
protein
sarscov
human
measur
elisa
result
confirm
virus
similar
proteinprotein
bind
curv
ec
figur
bind
curv
protein
express
cell
assess
use
fac
similar
bind
curv
ec
valu
obtain
two
virus
figur
experiment
result
consist
structur
model
analysi
indic
viru
like
infect
human
cell
similar
mechan
sarscov
viru
bind
human
compar
affin
henc
may
possess
similar
transmiss
serial
dilut
recombin
protein
sarscov
merscov
coat
well
plate
incub
recombin
fctag
bind
evalu
b
recombin
protein
sarscov
incub
cell
subject
fac
evalu
bind
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
coronaviru
mutat
emerg
escap
mutant
neutral
monoclon
antibodi
vaccin
major
concern
sarscov
two
differ
coronavirus
modest
level
sequenc
homolog
spike
protein
understand
whether
antibodi
rais
sarscov
spike
protein
immun
crossreact
new
offer
import
insight
guidanc
therapeut
antibodi
prophylact
vaccin
develop
sarscov
nab
gener
immun
mous
rabbit
sarscov
rbd
protein
two
sarscov
sprotein
rabbit
polyclon
antibodi
tabl
four
monoclon
antibodi
tabl
analyz
crossreact
protein
crossneutr
activ
psv
expect
polyclon
antibodi
show
weaker
bind
protein
ec
compar
sarscov
protein
ec
neutral
activ
psv
lower
twoorder
magnitud
sarscov
psv
tabl
present
pessimist
forecast
probabl
identifi
highli
potent
crossreact
nab
sarscov
antibodi
antibodi
librari
sarscov
monoclon
nab
strong
bind
ec
k
potent
activ
exhibit
potent
neutral
activ
sarscov
minimum
dose
reach
neutral
almost
crossbind
protein
ec
crossneutr
activ
psv
neutral
activ
tabl
figur
interestingli
three
monoclon
antibodi
show
modest
bind
activ
sarscov
protein
ec
neutral
activ
sarscov
psv
minimum
dose
reach
neutral
although
nab
less
potent
nab
sarscov
could
evid
crossbind
protein
ec
crossneutr
psv
neutral
activ
tabl
polyclon
antibodi
rabbit
immun
sarscov
protein
polyclon
antibodi
rabbit
immun
sarscov
rbd
protein
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
bind
sar
nab
sarscov
protein
test
elisa
recombin
protein
sarscov
coat
plate
serial
dilut
nab
ad
bind
recombin
protein
b
bind
sar
nab
protein
test
elsia
recombin
protein
coat
plate
serial
dilut
nab
ad
bind
recombin
protein
c
neutral
sarscov
nab
psv
antibodi
competit
sarscov
rbd
bind
recombin
sarscov
rbd
protein
coat
plate
nab
recombin
ad
rbd
bind
competit
measur
suggest
sarscov
rbd
sequenc
align
analysi
figur
rbm
sequenc
homolog
much
less
rbd
sequenc
homolog
structur
similar
analysi
confirm
presenc
signific
local
structur
differ
rbm
region
rest
rbd
region
significantli
higher
similar
figur
moreov
three
glycosyl
site
sarscov
rbd
ie
conserv
although
one
glycosyl
site
may
glycosyl
correspond
residu
predict
netnglyc
take
two
virus
rbd
structur
similar
glycosyl
site
account
predict
two
possibl
conserv
region
rbd
epitop
crossreact
neutral
antibodi
resid
region
probabl
overlap
bind
site
figur
specul
like
obtain
crossreact
nonblock
neutral
antibodi
target
conserv
region
outsid
rbm
region
neutral
mechan
nonblock
crossreact
antibodi
like
unrel
blockag
rbd
shown
spacefil
model
color
surfac
shown
gray
tube
model
three
glycosyl
site
sarscov
label
note
n
st
sarscov
chang
n
sa
differ
nxst
pattern
requir
glycosyl
henc
site
like
unglycosyl
two
possibl
crossreact
region
mark
yellow
circl
coronaviru
spike
protein
shown
respons
interact
host
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
cell
receptor
initi
infect
sarscov
sarscov
virus
use
human
cell
entri
due
natur
rna
viru
rapid
mutat
rate
chang
sprotein
amino
acid
sequenc
especi
rbd
receptor
bind
motif
could
signific
impact
viru
infect
pathogen
transmiss
crossprotect
previou
coronaviru
infect
well
therapeut
antibodi
prophylact
vaccin
develop
henc
understand
differ
sarscov
implic
may
offer
signific
scientif
practic
valu
though
difficult
assess
virushostcel
interact
real
virion
studi
new
headtohead
comparison
sarscov
use
multipl
method
measur
recombin
sarscov
spike
protein
recombin
protein
express
cell
confirm
two
coronavirus
similar
bind
affin
human
figur
b
provid
direct
molecular
base
evid
support
possibl
explain
observ
new
coronaviru
similar
transmiss
sarscov
viru
sinc
sarscov
coronavirus
sequenc
homolog
share
human
receptor
analyz
sarscov
antibodi
crossreact
may
provid
use
inform
whether
neutral
epitop
conserv
two
coronavirus
two
rabbit
polyclon
antibodi
produc
sarscov
rbd
protein
potent
bind
neutral
activ
sarscov
modest
crossbind
crossneutr
activ
new
viru
four
highli
potent
block
sarscov
monoclon
antibodi
show
bind
affin
sarscov
protein
rang
nm
pm
high
neutral
activ
sarscov
low
ugml
nab
lead
neutral
sarscov
psv
howev
virtual
crossbind
cross
neutral
activ
novel
viru
detect
four
block
monoclon
antibodi
screen
antibodi
rais
sarscov
rbd
neutral
activ
three
monoclon
antibodi
identifi
although
bind
affin
sarscov
protein
significantli
lower
ec
compar
ec
four
nab
signific
crossbind
activ
protein
modest
crossneutr
activ
psv
detect
observ
three
antibodi
bind
neutral
sarscov
without
block
suggest
follow
first
epitop
epitop
three
antibodi
conserv
across
two
significantli
differ
coronavirus
henc
possibl
mayb
challeng
identifi
antibodi
potent
neutral
activ
sarscov
ideal
mutant
viru
strain
well
second
epitop
epitop
three
nab
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
like
locat
outsid
rbm
motif
due
block
featur
fact
homolog
rbm
motif
two
virus
significantli
lower
rest
portion
rbd
analysi
mutat
rbd
also
conduct
analyz
sequenc
variant
gisaid
found
variant
mutat
rbd
one
two
one
align
sarscov
rbd
sequenc
collect
blast
via
ncbi
websit
use
consurf
analysi
shown
figur
sarscov
rbm
region
highli
variabl
make
challeng
develop
crossreact
antibodi
broad
spectrum
neutral
activ
mutant
strain
hand
signific
portion
rbd
mark
pink
outsid
rbm
motif
highli
conserv
neutral
antibodi
target
epitop
region
could
potenti
crossprotect
activ
differ
mutant
strain
also
noteworthi
three
nonblock
antibodi
neutral
activ
significantli
lower
four
block
antibodi
due
limit
number
antibodi
obtain
difficult
conclud
whether
consist
pattern
blockag
neutral
potenc
one
specul
neutral
antibodi
target
conserv
epitop
outsid
rbm
region
may
crossprotect
may
also
less
potent
due
lack
block
activ
recent
articl
sarscov
rbd
neutral
antibodi
epitop
outsid
rbm
motif
also
shown
nonblock
crossbind
rbd
rel
low
k
nm
neutral
mechan
nonblock
antibodi
clear
yet
known
antibodi
target
region
could
block
protein
configur
chang
henc
interfer
viru
entri
host
cell
whether
nonblock
rbd
antibodi
also
interfer
protein
configur
chang
remain
investig
summari
find
suggest
sarscov
bind
human
similar
affin
henc
may
similar
transmiss
antibodi
target
rbm
region
may
potent
due
block
activ
crossprotect
antibodi
target
rbm
region
may
difficult
obtain
lower
degre
sequenc
conserv
antibodi
conserv
region
outsid
rbm
motif
may
possess
crossprotect
neutral
activ
may
less
potent
due
lack
block
activ
mechan
neutral
nonblock
rbd
antibodi
remain
investig
develop
potent
crossprotect
therapeut
antibodi
vaccin
possibl
could
challeng
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
rbd
shown
color
surfac
shown
gray
cartoon
three
surfac
mutat
site
ie
observ
rbd
label
mutat
buri
shown
recombin
protein
cat
sarscov
cat
merscov
recombin
rbd
protein
sarscov
cat
transfect
reagent
sinofect
cat
mammalian
express
plasmid
full
length
rbd
protein
cat
sarscov
cat
cat
polyclon
antibodi
sarscov
cat
cat
purchas
sino
biolog
fetal
bovin
serum
fb
cat
sa
purchas
lanzhou
minhai
bioengin
hygromycin
cat
purchas
sigmaaldrich
sarscov
neutral
antibodi
gener
mice
rabbit
immun
recombin
protein
sarscov
luciferas
assay
system
cat
purchas
promega
human
embryon
kidney
cell
line
cat
use
pseudoviru
psv
packag
purchas
atcc
cell
establish
transfect
express
plasmid
cell
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
cell
grown
dulbecco
modifi
eagl
medium
dmem
contain
vv
fb
indic
protein
coat
well
plate
use
cb
buffer
night
bsa
use
block
room
temperatur
indic
correspond
protein
antibodi
ad
incub
room
temperatur
wash
away
unbound
protein
antibodi
secondari
antibodi
hrp
label
ad
incub
anoth
hour
wash
away
develop
buffer
ad
incub
min
h
ad
stop
reaction
absorb
detect
micropl
reader
indic
concentr
protein
sarscov
incub
cell
min
wash
away
unbound
protein
cell
incub
withp
label
antihistag
antibodi
min
went
flow
cytomet
detect
cellular
bind
flowjo
graphpad
softwar
use
data
analysi
recombin
sarscov
protein
biotin
load
use
sa
sensor
indic
antibodi
ad
real
time
associ
dissoci
analysi
data
analysi
octet
use
data
process
pseudoviru
product
adher
cell
hour
transfect
cell
preplat
flask
fb
cellscm
luciferaseexpress
lentivir
transfer
genom
pwpxlluc
packag
plasmid
psd
express
plasmid
encod
either
protein
pcmvwhcovspik
sarss
protein
pcmvsarsspik
cotransfect
preplat
cell
use
sinofect
transfect
reagent
accord
procedur
recommend
manufactur
transfect
cell
incub
incub
co
overnight
follow
medium
exchang
fresh
dmem
plu
fb
supernat
contain
pseudoviru
collect
hour
filter
filter
store
longtim
storag
short
time
storag
cell
plate
plate
cellswel
l
fb
serial
dilut
antibodi
sampl
sar
psv
mix
incub
hour
antibodypsv
mixtur
ad
onto
cell
well
incub
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
co
hour
infect
luciferas
luminesc
rlu
detect
use
luciferas
assay
system
accord
procedur
recommend
manufactur
luminesc
micropl
reader
antibodi
inhibit
calcul
follow
inhibiton
antibodi
neutral
titer
present
maxim
inhibitori
concentr
ic
protein
sequenc
align
perform
use
clustal
omega
sarscov
complex
structur
remodel
base
pdb
complet
miss
loop
use
discoveri
studio
ds
complex
structur
optim
rosetta
relax
complex
structur
construct
base
optim
sarscov
complex
structur
use
ds
also
optim
rosetta
relax
interfac
rbd
analyz
rosetta
interfac
analyz
ds
softwar
pymol
use
prepar
structur
figur
structur
similar
analysi
sarscov
carri
discoveri
studio
ds
structur
conserv
analysi
sarscov
rbd
carri
use
consurf
align
sarscov
rbd
sequenc
use
gener
sequenc
conserv
collect
blast
via
ncbi
websit
structur
conserv
display
pymol
authorfund
right
reserv
reus
allow
without
permiss
tabl
rbd
side
chain
interact
interfac
distanc
nearest
distanc
side
chain
rbd
residu
sb
saltbridg
hb
hydrogen
bond
pi
interact
np
nonpolar
interact
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
figur
realtim
associ
dissoci
monoclon
nab
detect
octet
system
figur
neutral
assay
monoclon
nab
sarscov
psv
authorfund
right
reserv
reus
allow
without
permiss
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
